ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 174 filers reported holding ACORDA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $42,000 | -54.3% | 60,939 | -66.0% | 0.00% | -100.0% |
Q3 2020 | $92,000 | -5.2% | 179,426 | +35.6% | 0.00% | -50.0% |
Q2 2020 | $97,000 | +31.1% | 132,272 | +262.3% | 0.00% | – |
Q4 2019 | $74,000 | -97.4% | 36,510 | -82.8% | 0.00% | -100.0% |
Q1 2019 | $2,814,000 | +62.3% | 211,765 | +90.2% | 0.03% | +50.0% |
Q4 2018 | $1,734,000 | -30.3% | 111,325 | -12.1% | 0.02% | -33.3% |
Q3 2018 | $2,488,000 | +647.1% | 126,597 | +991.4% | 0.03% | +650.0% |
Q2 2018 | $333,000 | -38.0% | 11,600 | -49.0% | 0.00% | -55.6% |
Q1 2018 | $537,000 | -30.6% | 22,726 | -38.4% | 0.01% | -57.1% |
Q1 2017 | $774,000 | +7.9% | 36,880 | -3.3% | 0.02% | -27.6% |
Q4 2016 | $717,000 | – | 38,136 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PFM Health Sciences, LP | 1,526,174 | $1,423,000 | 0.12% |
GSA CAPITAL PARTNERS LLP | 250,271 | $233,000 | 0.06% |
Spark Investment Management LLC | 110,300 | $102,000 | 0.05% |
SALZHAUER MICHAEL | 30,000 | $28,000 | 0.05% |
HAP Trading, LLC | 260,800 | $532,000 | 0.04% |
Point72 Asset Management, L.P. | 1,589,600 | $1,482,000 | 0.01% |
DLD Asset Management, LP | 208,400 | $196,000 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 1,893,678 | $1,765,000 | 0.01% |
EVERENCE CAPITAL MANAGEMENT INC | 65,680 | $61,000 | 0.01% |
Benin Management CORP | 11,714 | $11,000 | 0.01% |